Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
Journal of Clinical Medicine · 05.09.2023 · 12 (18) · 5784
DOI: 10.3390/jcm12185784 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 05.09.2023. Verfasst von Roberto Galea und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Patients with atrial fibrillation (AF) experiencing ischemic stroke despite oral anticoagulation (OAC), i.e., breakthrough strokes, are not uncommon, and represent an important clinical subgroup in view of the consistently high risk of stroke recurrence and mortality. The understanding of the heterogenous potential mechanism underlying OAC failure is essential in order to implement specific therapeutic measures aimed at reducing the risk of recurrent ischemic stroke. However, due to the incomplete comprehension of this phenomenon and the limited available data, secondary stroke prevention in such high-risk patients represents a clinical dilemma. There are several available strategies to prevent ischemic stroke recurrence in AF patients with breakthrough stroke in the absence of competing causes unrelated to AF, and these include continuation or change in the type of OAC, addition of antiplatelet therapy, left atrial appendage closure, or any combination of the above options. However, due to the limited available data, the latest guidelines do not provide any specific recommendations about which of the above strategies may be preferred. This review describes the incidence, the clinical impact and the potential mechanisms underlying OAC failure in AF patients. Furthermore, the evidence supporting each of the above therapeutic options for secondary stroke prevention and the potential future directions will be discussed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
- Department of Neurology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
ORCID-Profile: David Seiffge
Zitieren
APA
Galea, R., Seiffge, D., & Räber, L. (2023). Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation. Journal of Clinical Medicine, 12(18), 5784. https://doi.org/10.3390/jcm12185784
Vancouver
Galea R, Seiffge D, Räber L. Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation. Journal of Clinical Medicine. 2023;12(18):5784. doi:10.3390/jcm12185784
BibTeX
@article{Galea2023,
author = {Galea, Roberto and Seiffge, David and Räber, Lorenz},
title = {Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {18},
pages = {5784},
doi = {10.3390/jcm12185784}
}
EUVIMED